Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory
- 31 December 2006
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 28 (6) , 574-577
- https://doi.org/10.1016/j.ijantimicag.2006.07.013
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antifungals in Systemic Neonatal CandidiasisDrugs, 2004
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998Antimicrobial Agents and Chemotherapy, 2001
- Antifungal Agents. Part I. Amphotericin B Preparations and FlucytosineMayo Clinic Proceedings, 1998
- Management of deepCandida infection in surgical and intensive care unit patientsIntensive Care Medicine, 1994
- Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonatesThe Journal of Pediatrics, 1990
- Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitisThe American Journal of Medicine, 1987
- Candida Meningitis in the NewbornSouthern Medical Journal, 1979
- FlucytosineAnnals of Internal Medicine, 1977
- Flucytosine. An effective oral treatment for chromomycosisArchives of Dermatology, 1974
- Pharmacokinetic Studies on the Oral Antimycotic Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney FunctionChemotherapy, 1973